Pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of HOMRE Ltd met on January 28, 2026 and took three key decisions. First, the proposal to issue share warrants convertible into equity shares to the promoters on a preferential basis was deferred to a future Board meeting, with no new timeline announced. Second, Mr. Ashok Chopra, a Chemical Engineering IIT Delhi graduate with 30+ years of experience in Oil & Gas and EPC, was appointed as a Non-Executive Independent Director for one year. Third, Mr. Mahesh Mahadeo Kadam resigned as Non-Executive Independent Director, effective the same day, citing personal reasons.
The deferral of the promoter-fund infusion via warrants removes near-term clarity on capital raising, which may keep the stock rangebound until the proposal is revived. The director churn (one resignation, one new appointment) is routine but worth monitoring for any governance signals.